Literature DB >> 12889605

Breast cancer diagnosis by scintimammography: a meta-analysis and review of the literature.

Moishe Liberman1, Fotini Sampalis, David S Mulder, John S Sampalis.   

Abstract

Scintimammography is a relatively new, non-invasive diagnostic modality in the evaluation of breast cancer. The purpose of the current study was to review the existing literature on the accuracy of scintimammography in the diagnosis of breast cancer. A search of all articles published between 1st January 1967 and 31st December 1999 was conducted. A total of 64 unique studies were selected. Each scientific paper was reviewed for scientific merit by an epidemiologist, a surgeon and a surgical resident. Assessment of scientific merit was based on a scoring scheme developed for the study. The articles included in this review reported data on a total of 5340 patients assessed for breast cancer with scintimammography. The aggregated summary estimates on these patients were sensitivity: 85.2% and specificity: 86.6%. For patients with a palpable mass the sensitivity and specificity were 87.8 and 87.5%, respectively. For patients without a palpable mass the sensitivity was 66.8% and that for specificity was 86.9%. The results of this review have shown that scintimammography may be used effectively as an adjunct to mammography and physical examination in the diagnosis of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12889605     DOI: 10.1023/A:1024417331304

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  20 in total

1.  Diagnostic efficiency of sestamibi gammagraphy and Doppler sonography in the preoperative assessment of breast lesions.

Authors:  Antonio Piñero; Pedro José Galindo; Julián Illana; Francisco Nicolás; Manuel Reus; María Dolores Hernández; Isidro Durán; Manuel Canteras; Pascual Parrilla
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

Review 2.  Nuclear imaging of the breast: translating achievements in instrumentation into clinical use.

Authors:  Carrie B Hruska; Michael K O'Connor
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

3.  Molecular breast imaging: an emerging modality for breast cancer screening.

Authors:  Michael K O'Connor
Journal:  Breast Cancer Manag       Date:  2015-01-01

4.  Tc-99m tetrofosmin scintimammography for the detection of recurrent breast cancer in a patient with equivocal mammography study.

Authors:  Samir Hussein; Sukhpal Sawhney; Adil Al-Jarrah
Journal:  Sultan Qaboos Univ Med J       Date:  2008-03

5.  Added value of semi-quantitative breast-specific gamma imaging in the work-up of suspicious breast lesions compared to mammography, ultrasound and 3-T MRI.

Authors:  T Meissnitzer; A Seymer; P Keinrath; J Holzmannhofer; C Pirich; K Hergan; M W Meissnitzer
Journal:  Br J Radiol       Date:  2015-04-17       Impact factor: 3.039

Review 6.  Breast cancer imaging: a perspective for the next decade.

Authors:  Andrew Karellas; Srinivasan Vedantham
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

7.  Breast scintigraphy today: indications and limitations.

Authors:  Orazio Schillaci; John R Buscombe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-23       Impact factor: 9.236

8.  Diagnostic Performance of Breast-Specific Gamma Imaging (BSGI) for Breast Cancer: Usefulness of Dual-Phase Imaging with (99m)Tc-sestamibi.

Authors:  Ji Sun Park; Ah Young Lee; Kyung Pyo Jung; Su Jung Choi; Seok Mo Lee; Sang Kyun Bae
Journal:  Nucl Med Mol Imaging       Date:  2012-10-13

Review 9.  The choice of the correct imaging modality in breast cancer management.

Authors:  Emilio Bombardieri; Luca Gianni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-04       Impact factor: 9.236

10.  Modern breast cancer detection: a technological review.

Authors:  Adam B Nover; Shami Jagtap; Waqas Anjum; Hakki Yegingil; Wan Y Shih; Wei-Heng Shih; Ari D Brooks
Journal:  Int J Biomed Imaging       Date:  2009-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.